An intracellular delivery vehicle for protein transduction of micro-dystrophin

Journal of Drug Targeting

Volumn 13, Issue 2, 2005, Pages 81-87

  Weisbart, Richard H ^a,e   Hansen, James E ^b   Nishimura, Robert N ^b   Chan, Grace ^a   Wakelin, Rika ^a   Chang, Sophia S ^b   Baresi, Larry ^c   Chamberlain, Jeffrey S ^d  

^a VA Greater Los Angeles Healthcare ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antibody; Dystrophin; Muscular dystrophy; Transport

Indexed keywords

BETA DYSTROGLYCAN PROTEIN; COMPLEMENTARY DNA; DRUG CARRIER; DYSTROPHIN; HYBRID PROTEIN; MEMBRANE PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MEMBRANE; CELL STRAIN COS7; CYTOPLASM; DRUG DELIVERY SYSTEM; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MUSCLE CELL; MYOBLAST; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PICHIA PASTORIS; PLASMID; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING; PROTEIN TRANSPORT; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; CYTOPLASM; DYSTROGLYCANS; DYSTROPHIN; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LYMPHOKINES; MYOBLASTS; PICHIA; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SIALOGLYCOPROTEINS; TRANSFECTION;

EID: 17444399039     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860400029002     Document Type: Article

References (20)

1. Ahmad A, Brinson M, Hodges BL, Chamberlain JS, Amalfitano A. 2000. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy. Hum Mol Genet 9:2507-2515.
2. Allen DL, Leinwand LA. 2001. Postnatal myosin heavy chain isoform expression in normal mice and null for IIb or IId myosin heavy chains. Dev Biol 229:383-395.
3. Chamberlain JS. 2002. Gene therapy of muscular dystrophy. Hum Mol Genet 11:2355-2362.
4. Derossi D, Joliot AH, Chassaing G, Prochiantz A. 1994. The third helix of the antennapedia homeodomain translocates through biological membranes. J Biol Chem 269:10444-10450.
5. Flora G, Lee YW, Nath A, Hennig B, Maragos W, Toborek M. 2003. Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp Neuro 179:60-70.
6. Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, Phelps SF, Harper HA, Robinson AS, Engelhardt JF, Brooks SV, Chamberlain JS. 2002. Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8:253-261.
7. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509-517.
8. Lee CC, Pearlman JA, Chamberlain JS, Caskey CT. 1991. Expression of recombinant dystrophin and its localization to the cell membrane. Nature 349:334-336.
9. McAllister RM, Melnyk J, Finkelstein JZ, Adams JR, EC, Gardner MB. 1969. Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 24:520-526.
10. Moulton HM, Hase MC, Smith KM, Iversen PL. 2003. HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers. Antisense Nucl Acid Drug Dev 13:31-43.
11. Phelan A, Elliott G, O'Hare P. 1998. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotech 16:440-443.
12. Phelps SF, Hauser MA, Cole NM, Rafael JA, Hinkle RT, Faulkner JA, Chamberlain JS. 1995. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum Mol Genet 4:1251-1258.
13. Prochiantz A. 2000. Messenger proteins: Homeoproteins, TAT and others. Curr Opin Cell Biol 12:400-406.
14. Richler C, Yaffe D. 1970. The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev Biol 23:1-22.
15. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SP. 1999. In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science 285:1569-1572.
16. Wang B, Li J, Xiao X. 2000. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci 97:13714-13719.
17. Weisbart RH, Stempniak M, Harris S, Zack DJ, Ferreri K. 1998. An autoantibody is modified for use as a delivery system to target the cell nucleus: Therapeutic implications. J Autoimmun 11:539-546.
18. Weisbart RH, Miller CW, Chan G, Wakelin R, Ferreri K, Koeffler HP. 2003a. Nuclear delivery of p53 C-terminal peptides into cancer cells using scFv fragments of a monoclonal antibody that penetrates living cells. Cancer Lett 195:211-219.
19. Weisbart RH, Yang F, Chan G, Wakelin R, Ferreri K, Zack DJ, Harrison B, Leinwand LA, Cole GM. 2003b. Cell type specific targeted intracellular delivery into muscle of a monoclonal antibody that binds myosin IIb. Mol Immunol 39:783-789.
20. Zack DJ, Stempniak M, Wong AL, Taylor C, Weisbart RH. 1996. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J Immunol 157:2082-2088.